Total Payments
$1,854
2024 Payments
$188.39
Companies
10
Transactions
25
Medicare Patients
991
Medicare Billing
$115,459
Payment Breakdown by Category
Food & Beverage$1,854 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,854 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,244 | 12 | $0 (2023) |
| ABBVIE INC. | $124.99 | 1 | $0 (2024) |
| PFIZER INC. | $113.74 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $102.86 | 1 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $99.40 | 1 | $0 (2018) |
| Lilly USA, LLC | $71.06 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $51.26 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $16.98 | 1 | $0 (2022) |
| Abbott Laboratories | $16.67 | 1 | $0 (2022) |
| Novo Nordisk Inc | $12.64 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188.39 | 4 | ABBVIE INC. ($124.99) |
| 2023 | $419.97 | 5 | Janssen Pharmaceuticals, Inc ($374.05) |
| 2022 | $112.81 | 3 | Janssen Pharmaceuticals, Inc ($79.16) |
| 2021 | $335.71 | 3 | Janssen Pharmaceuticals, Inc ($335.71) |
| 2019 | $100.67 | 1 | Janssen Pharmaceuticals, Inc ($100.67) |
| 2018 | $353.66 | 4 | Janssen Pharmaceuticals, Inc ($140.52) |
| 2017 | $342.29 | 5 | Janssen Pharmaceuticals, Inc ($213.79) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $133.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: PSYCHIATRY | ||||||
| 06/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $115.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $79.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/09/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: VACCINES | ||||||
| 02/27/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes Care | ||||||
| 08/26/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $102.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $108.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/24/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $100.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/21/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $67.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/06/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $99.40 | General |
| 08/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $72.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/07/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $113.74 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/07/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/26/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $102.86 | General |
| Category: DIABETES | ||||||
| 07/24/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Diabetes | ||||||
| 07/20/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $89.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/24/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 164 | 346 | $60,372 | $19,185 |
| 2022 | 8 | 228 | 527 | $90,064 | $28,686 |
| 2021 | 7 | 278 | 527 | $94,496 | $31,340 |
| 2020 | 7 | 321 | 794 | $109,937 | $36,248 |
Total Patients
991
Total Services
2,194
Medicare Billing
$115,459
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 152 | $38,152 | $12,598 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 93 | $16,554 | $4,558 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,586 | $1,143 | 31.9% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 20 | 20 | $722.00 | $634.40 | 87.9% |
| 90471 | Administration of vaccine | Office | 2023 | 14 | 14 | $462.00 | $214.48 | 46.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 56 | $896.00 | $38.14 | 4.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 215 | $53,965 | $18,339 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 155 | $27,590 | $7,633 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,564 | $1,357 | 29.7% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 22 | 22 | $1,012 | $629.37 | 62.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $605.00 | $312.18 | 51.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 28 | $812.00 | $224.39 | 27.6% |
| 90471 | Administration of vaccine | Office | 2022 | 12 | 12 | $396.00 | $140.80 | 35.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 12 | 70 | $1,120 | $49.44 | 4.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 194 | $49,082 | $16,391 | 33.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 82 | 207 | $36,846 | $11,757 | 31.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,597 | $1,115 | 31.0% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 38 | 38 | $1,748 | $1,078 | 61.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 39 | 39 | $2,145 | $642.33 | 29.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 24 | $672.00 | $242.88 | 36.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 14 | $406.00 | $114.70 | 28.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 110 | 251 | $54,086 | $18,460 | 34.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 117 | 283 | $41,554 | $12,636 | 30.4% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 15 | 15 | $6,977 | $2,852 | 40.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $4,815 | $1,688 | 35.1% |
About Dr. Nelson Mata, MD
Dr. Nelson Mata, MD is a Internal Medicine healthcare provider based in San Juan, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518931377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nelson Mata, MD has received a total of $1,854 in payments from pharmaceutical and medical device companies, with $188.39 received in 2024. These payments were reported across 25 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,854).
As a Medicare-enrolled provider, Mata has provided services to 991 Medicare beneficiaries, totaling 2,194 services with total Medicare billing of $115,459. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location San Juan, TX
- Active Since 02/16/2006
- Last Updated 02/28/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518931377
Products in Payments
- XARELTO (Drug) $1,054
- INVOKANA (Drug) $190.30
- TEFLARO (Drug) $124.99
- LYRICA (Drug) $113.74
- JARDIANCE (Drug) $102.86
- MOUNJARO (Drug) $58.06
- REXULTI (Drug) $51.26
- SHINGRIX (Biological) $16.98
- FREESTYLE LIBRE 2 (Device) $16.67
- TRULICITY (Drug) $13.00
- Victoza (Drug) $12.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Juan
Eric Carro Jimenez, Md, MD
Internal Medicine — Payments: $603,965
Internal Medicine $603,965
Dr. Alexis Cruz-Chacon, Md, MD
Internal Medicine — Payments: $486,831
Internal Medicine $486,831
Ricardo Fernandez, Md, MD
Internal Medicine — Payments: $419,840
Internal Medicine $419,840
Cristina Ramos, M.d, M.D
Internal Medicine — Payments: $415,435
Internal Medicine $415,435
Mirelis Acosta, M.d, M.D
Internal Medicine — Payments: $229,288
Internal Medicine $229,288
Cristian Rodriguez Arocho, Md, MD
Internal Medicine — Payments: $187,448
Internal Medicine $187,448